Global Active Pharmaceutical Ingredients Market, by API (Branded/ Innovative and Generic), by Type of Synthesis (Synthetic and Biotech), by Application (Diabetes, Oncology, Cardiovascular, CNS, Analgesics, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 153.4 billion in 2017 and is projected to exhibit a CAGR of 6.8% over the forecast period (2018 – 2026), as highlighted in a new report published by . Increasing investment in research and development by manufacturers to augment the market growth Increasing number of major pharmaceutical companies are continuously focusing on expansion of their product line in high potency API (HPAPIs) or considering investing in new HPAPIs production facilities, further outsourcing the manufacturing of APIs to contract manufacturers. This in turn will increase the benefits from the latter’s competency and expertise, as captive manufacturing of HPAPIs is expensive and requires stringent safety and handling specifications. This is expected to boost growth of the active pharmaceutical ingredients market. The outsourcing of APIs manufacturing is increasing in India, China, and Eastern European countries due to the low cost of manufacturing in these countries as compared to North America and Western Europe regions. For instance, in October 2017, Piramal Pharma Solutions (PPS), a contract development and manufacturing organization, invested US$ 55 million across its sites in Asia, to expand its API manufacturing capabilities and capacities. Moreover, in October 2018, Lonza, the Swiss biopharma CDMO, expanded its highly potent active pharmaceutical ingredient (HPAPI) capacity for the specific support of antibody-drug conjugate (ADC) payload manufacturing. It added two new manufacturing suites at its Visp site for the manufacturing of antibody-drug conjugate (ADC) payload. Browse 32 Market Data Tables and 20 Figures spread through 178 Pages and in-depth TOC on “Active Pharmaceutical Ingredients Market”- Global Forecast to 2026, by API (Branded/ Innovative and Generic), by Type of Synthesis (Synthetic and Biotech), by Application (Diabetes, Oncology, Cardiovascular, CNS, Analgesics, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) To know the latest trends and insights prevalent in the active pharmaceutical ingredients market, click the link below: https://www.coherentmarketinsights.com/market-insight/active-pharmaceutical-ingredients-market-738 High potency active pharmaceutical ingredients are considered as a growth opportunity for pharmaceutical manufacturers and contract manufacturing organizations (CMOs) with much R&D focusing on more specialized medicines especially in the field of oncology. Increasing demand for antibody drug conjugates (ADC) is expected to propel the active pharmaceutical ingredients market growth. According to IMS Institute of Healthcare Informatics, 2016, 586 drugs were under development for oncology treatment, with over 70 new cancer treatments (for over 20 tumor types) that entered the market over the past five years (2010-2015). Key Takeaways of the Active Pharmaceutical Ingredients Market:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.